2014 Q1 Form 10-Q Financial Statement

#000119312514175537 Filed on May 01, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $28.94M $23.75M
YoY Change 21.84% 43.66%
Cost Of Revenue $9.255M $7.066M
YoY Change 30.98% 58.79%
Gross Profit $19.68M $16.69M
YoY Change 17.97% 38.06%
Gross Profit Margin 68.02% 70.25%
Selling, General & Admin $15.40M $13.27M
YoY Change 16.0% 37.68%
% of Gross Profit 78.21% 79.54%
Research & Development $2.974M $2.503M
YoY Change 18.82% 44.68%
% of Gross Profit 15.11% 15.0%
Depreciation & Amortization $1.304M $1.171M
YoY Change 11.36% 37.76%
% of Gross Profit 6.62% 7.02%
Operating Expenses $19.09M $16.49M
YoY Change 15.73% 41.81%
Operating Profit $598.0K $194.0K
YoY Change 208.25% -57.73%
Interest Expense $50.00K $20.00K
YoY Change 150.0% 0.0%
% of Operating Profit 8.36% 10.31%
Other Income/Expense, Net -$7.000K -$61.00K
YoY Change -88.52% -12.86%
Pretax Income $591.0K $133.0K
YoY Change 344.36% -67.56%
Income Tax $218.0K -$66.00K
% Of Pretax Income 36.89% -49.62%
Net Earnings $373.0K $199.0K
YoY Change 87.44% -22.27%
Net Earnings / Revenue 1.29% 0.84%
Basic Earnings Per Share $0.02 $0.01
Diluted Earnings Per Share $0.02 $0.01
COMMON SHARES
Basic Shares Outstanding 16.16M shares 14.88M shares
Diluted Shares Outstanding 16.83M shares 15.56M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $134.6M $72.60M
YoY Change 85.4% 119.34%
Cash & Equivalents $134.6M $72.56M
Short-Term Investments
Other Short-Term Assets $13.60M $12.30M
YoY Change 10.57% 39.77%
Inventory
Prepaid Expenses
Receivables $12.17M $10.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $160.4M $95.70M
YoY Change 67.58% 92.17%
LONG-TERM ASSETS
Property, Plant & Equipment $9.479M $7.600M
YoY Change 24.72% 123.53%
Goodwill $25.49M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $197.0K $14.50M
YoY Change -98.64% 0.69%
Total Long-Term Assets $66.18M $67.10M
YoY Change -1.37% 129.79%
TOTAL ASSETS
Total Short-Term Assets $160.4M $95.70M
Total Long-Term Assets $66.18M $67.10M
Total Assets $226.6M $162.8M
YoY Change 39.16% 106.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.243M $2.000M
YoY Change 12.15% 66.67%
Accrued Expenses $3.069M $7.800M
YoY Change -60.65% 32.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.50M $15.60M
YoY Change 24.99% 39.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.00M $10.20M
YoY Change 17.65% 39.73%
Total Long-Term Liabilities $12.00M $10.20M
YoY Change 17.65% 39.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.50M $15.60M
Total Long-Term Liabilities $12.00M $10.20M
Total Liabilities $31.46M $25.80M
YoY Change 21.95% 39.46%
SHAREHOLDERS EQUITY
Retained Earnings -$46.42M
YoY Change
Common Stock $241.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $195.1M $137.0M
YoY Change
Total Liabilities & Shareholders Equity $226.6M $162.8M
YoY Change 39.16% 106.08%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $373.0K $199.0K
YoY Change 87.44% -22.27%
Depreciation, Depletion And Amortization $1.304M $1.171M
YoY Change 11.36% 37.76%
Cash From Operating Activities $3.560M $6.550M
YoY Change -45.65% 309.38%
INVESTING ACTIVITIES
Capital Expenditures $861.0K $1.089M
YoY Change -20.94% -272.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$860.0K -$1.090M
YoY Change -21.1% 73.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 610.0K 1.050M
YoY Change -41.9% 950.0%
NET CHANGE
Cash From Operating Activities 3.560M 6.550M
Cash From Investing Activities -860.0K -1.090M
Cash From Financing Activities 610.0K 1.050M
Net Change In Cash 3.310M 6.510M
YoY Change -49.16% 508.41%
FREE CASH FLOW
Cash From Operating Activities $3.560M $6.550M
Capital Expenditures $861.0K $1.089M
Free Cash Flow $2.699M $5.461M
YoY Change -50.58% 144.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66050000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16092121 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16092121 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.62
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1097223 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2801000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1798000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18915000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7981000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
192773000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
239549000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
237000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46792000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6335000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7788000
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2857000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
16000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
223330000
CY2013Q4 us-gaap Liabilities
Liabilities
30557000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
8785000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Assets Current
AssetsCurrent
156075000
CY2013Q4 us-gaap Goodwill
Goodwill
25487000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
210000
CY2013Q4 us-gaap Deferred Costs
DeferredCosts
3684000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
10870000
CY2013Q4 us-gaap Assets
Assets
223330000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131294000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11611000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17082000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24870000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2850000
CY2013Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
9048000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1272000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9922000
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16203384 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72559000
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16182693 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
684071 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16182693 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.91
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1142222 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2600000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.74
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3069000
CY2014Q1 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2243000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19499000
CY2014Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7694000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
195097000
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
241500000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
233000
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
20000000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46419000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6493000
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8505000
CY2014Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2762000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
16000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
226559000
CY2014Q1 us-gaap Liabilities
Liabilities
31462000
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9201000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4620000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
160377000
CY2014Q1 us-gaap Goodwill
Goodwill
25487000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
197000
CY2014Q1 us-gaap Deferred Costs
DeferredCosts
3957000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2062000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
10697000
CY2014Q1 us-gaap Assets
Assets
226559000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134603000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12166000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2578000
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16365000
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24870000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2797000
CY2014Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
9539000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2578000
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11500000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2557000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1272000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1970000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9479000
CY2014Q1 spsc Employee Stock Purchase Plan Employees Contribution
EmployeeStockPurchasePlanEmployeesContribution
369000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
924000
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
80000
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15564000 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6509000
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9225000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1089000
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
214000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6549000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
177000
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
7066000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2503000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1049000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1171000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
717000
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
627000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14884000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
51000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
2000 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
201000 shares
CY2013Q1 us-gaap Revenues
Revenues
23752000
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2831000
CY2013Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
778000
CY2013Q1 us-gaap Gross Profit
GrossProfit
16686000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-84000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
23000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
194000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
133000
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-72000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
199000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1089000
CY2013Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
659000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4047000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1049000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-72000
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
355000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
16492000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-66000
CY2014Q1 dei Trading Symbol
TradingSymbol
SPSC
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
SPS COMMERCE INC
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001092699
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
Seven to ten years
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16830000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
38.94
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-09-30
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.95
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3558000
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
616000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.24
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.95
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
119143 shares
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16155000 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
65077 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
57000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
2000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9067 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
120000 shares
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <i>Use of Estimates</i></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p> </div>
CY2014Q1 us-gaap Revenues
Revenues
28939000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-66000
CY2014Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
764000
CY2014Q1 us-gaap Gross Profit
GrossProfit
19684000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-56000
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
49000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
598000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
591000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
712000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
373000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
861000
CY2014Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-82000
CY2014Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-287000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4511000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
612000
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
173000
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
574000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1339000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
157000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3309000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10884000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-861000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
255000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
445000
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
9255000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2974000
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
587000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1304000
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
25000
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
717000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
19086000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218000
CY2014Q1 spsc Percentage Of Common Stock On Fair Market Value
PercentageOfCommonStockOnFairMarketValue
0.85 pure
CY2014Q1 spsc Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unissued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnissuedInPeriod
4942 shares
CY2014Q1 spsc Number Of Offerings During Year
NumberOfOfferingsDuringYear
2 OfferingPeriods

Files In Submission

Name View Source Status
0001193125-14-175537-index-headers.html Edgar Link pending
0001193125-14-175537-index.html Edgar Link pending
0001193125-14-175537.txt Edgar Link pending
0001193125-14-175537-xbrl.zip Edgar Link pending
d702293d10q.htm Edgar Link pending
d702293dex311.htm Edgar Link pending
d702293dex312.htm Edgar Link pending
d702293dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spsc-20140331.xml Edgar Link completed
spsc-20140331.xsd Edgar Link pending
spsc-20140331_cal.xml Edgar Link unprocessable
spsc-20140331_def.xml Edgar Link unprocessable
spsc-20140331_lab.xml Edgar Link unprocessable
spsc-20140331_pre.xml Edgar Link unprocessable